Home
About
Overview
Management Team
Board of Directors
Product Pipeline
Overview
Meloxicam
Dexmedetomidine
Fadolmidine
Therapeutics Market
News & Investors
Investors
Overview
Press Releases
Events
Presentations
Governance
Governance Documents
Board of Directors
Board Committees
Stock Info
Quote
Financial & Filings
Financial & Filings
SEC Filings
Contact
Careers
Home
News & Investors
Press Releases
Press Releases
All News
2019
2018
2017
2016
2015
2014
Recro Pharma Announces Pricing of Its Initial Public Offering
March 7, 2014
« Previous
1...
6
7
8
9
10
11
12
13
14
15
